Emerging clinical experience with vaccines against group B meningococcal disease
<p>The prevention of paediatric bacterial meningitis and septicaemia has recently entered a new era with the availability of two vaccines against capsular group B meningococcus (MenB). Both of these vaccines are based on sub-capsular proteins of the meningococcus, an approach that overcomes th...
| Hauptverfasser: | , |
|---|---|
| Format: | Journal article |
| Veröffentlicht: |
Elsevier
2017
|